CRYbetaB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer. Yan Y, Narayan A, Cho S, Cheng Z, et al. Oncogene 2021 Aug 2. pii: 10.1038/s41388-021-01975.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yan Y, Narayan A, Cho S, Cheng Z, et al. CRYbetaB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer. Oncogene 2021 Aug 2. pii: 10.1038/s41388-021-01975.
PMID: 34341513